Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Dioxopromethazine hydrochloride
Cat. No.:
OB0225LY-0145
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Dioxopromethazine hydrochloride is a drug with antihistamine and sedative properties.
Synonym:
15374-15-9; 1-(5,5-Dioxophenothiazin-10-yl)-N, N-dimethylpropan-2-amine; hydrochloride; N-(2-Dimethylaminopropyl)phenothiazine S,S)-dioxide hydrochloride; Phenothiazine, 10-(2-(dimethylamino)propyl)-, 5,5-dioxide, monohydrochloride; 10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl-, 5,5-dioxide, hydrochloride (1:1); 10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl-, 5,5-dioxide, monohydrochloride
CAS No.:
15374-15-9
Compound CID:
11416891
Formula:
C17H20N2O2S·HCl
Formula Weight:
352.88
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Dioxopromethazine hydrochloride can be used for anti-allergy drug development and tranquilizer research.
Library Information
Targets:
Histamine receptor
Receptors:
H1 receptor
Pathways:
Immunology/Inflammation; Neuronal signaling; GPCR/G protein
Plate Number:
AOCL-2
Plate Location:
g8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
10 mg/mL; 28.34 mM
